The impact of cardiac complications on outcome in the SAH population

E A Crago1, M E Kerr, Y Kong

  • 1University of Pittsburgh School of Nursing, Pittsburgh, PA 15261, USA. ecrago@pitt.edu

Insights

Cardiac complications negatively impact outcomes for acute subarachnoid hemorrhage (SAH) patients. These effects on quality of life and daily functioning were observed up to six months post-hemorrhage.

Area of Science:

  • Neurology
  • Cardiology
  • Critical Care Medicine

Background:

  • Acute subarachnoid hemorrhage (SAH) is a critical neurological event.
  • Cardiac complications (CdCs) are common in SAH patients.
  • The impact of CdCs on SAH patient outcomes requires further elucidation.

Purpose of the Study:

  • To investigate the association between cardiac complications (CdCs) and patient outcomes following aneurysmal subarachnoid hemorrhage (SAH).

Main Methods:

  • Eighty-one adult aneurysmal SAH patients with significant neurological deficits were enrolled.
  • Cardiac complications included ECG changes, myocardial necrosis, arrhythmias, and pulmonary edema.
  • Patient outcomes were assessed at 3, 6, and 12 months using validated scales (MRS, GOS, Barthel Index, SF-36).

Main Results:

  • Cardiac complications occurred in 33% of SAH patients, with arrhythmias and pulmonary edema being most frequent.
  • No significant difference in mortality was observed between patients with and without CdCs.
  • Significant differences in functional outcomes (Barthel, SF-36) and trends in GOS and MRS were noted at 3 months, with SF-36 differences persisting at 6 months.

Conclusions:

  • Cardiac complications may exert a negative influence on the functional outcomes of SAH patients.
  • The impact of CdCs on patient recovery and quality of life is evident up to six months post-hemorrhage.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...